P2RY1 and Thromboembolism: MRS2500, an adenosine analog developed as a specific P2Y1 antagonist, has been shown to provide strong protection against systemic thromboembolism upon intravenous injection of collagen and adrenalin in mice, while only moderately prolonging bleeding time (47), and exhibited antithrombotic effects in cynomolgus monkeys (48).